Drugmakers slash prices to be eligible for China's bulk-buy program




Drugmakers slash prices to be eligible for China's bulk-buy program


BEIJING (Reuters) - Global pharmaceutical majors and generic drugmakers chopped by 53% on average prices of some of their off-patent products in the latest bidding round under China's national bulk-buy program, government officials said late on Friday.

Beijing has been pushing forward the program where drugmakers have to go through a bidding process and cut prices low enough to be considered over generic copies and be allowed to sell their products at public hospitals via large-volume government procurement.

Some global firms such as AstraZeneca (L:AZN) and Merck (N:MRK) have already cautioned about intensifying price pressures on their mature brands in the world's second largest drug market, as China expands the usage of the program.

In the latest bidding on Friday that involved 33 drugs and 122 companies, Bayer (DE:BAYGn) slashed the price of its popular diabetes treatment Acarbose to 0.18 yuan ($0.0262) per pill, 78.5% lower than the price ceiling set by the government in December last year, elbowing some Chinese generic providers out of the tender, according to a Reuters calculation based on the preliminary results released by the authority overseeing the program.

Bayer was not immediately available for a comment.

"Products that won bids in this round of centralized procurement saw a huge price drop, which squeezes out unreasonable overpricing that has existed in drug distribution for a long time," the authority said in a statement published alongside the preliminary result on Friday.

Sale prices of over 100 types of commonly used drugs are on average about 17 to 18 times of their manufacturing costs, the statement said.

Chinese copycats won bids for most of the 33 drugs, including generic versions for drugs ranging from Johnson & Johnson's (N:JNJ) prostate cancer treatment Zytiga to Eli Lilly's (N:LLY) erectile dysfunction treatment Cialis, the results showed.

In Friday's bidding, for products with two bid winners, 60% of the government procurement volume can be shared among the winners, according to official document detailing the tender rules released in December. For products with four winners and more, as much as 80% of the volume can be shared among the companies.

In the first round of the nationwide implementation of the bulk-buy program in September, global drugmakers including Sanofi (PA:SASY) and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers.





Related News

Metro Bank likely to pick interim boss as next CEO: Sky News
Today, 00:15
(Reuters) - Britain's Metro Bank (L:MTRO) is likely to pick acting boss Daniel Frumkin as its next chief executive, Sky News reported https://news.sky.com/story/metro-bank-faces-pressure-to-hand-interim-chief-top-job-11936657 on Monday, citing
Gazprom deputy CEO Sereda moved to new role at export unit
Today, 00:12
MOSCOW (Reuters) - Gazprom (MCX:GAZP) deputy chief executive officer Mikhail Sereda is to take up a new role at the Russian gas giant's exporting arm, the company said on Monday. Sereda, 49, who is close to Gazprom chief executive Alexei
Spanish supermarket chain Dia appoints new Brazil CEO to lead restructuring
Today, 00:09
SAO PAULO (Reuters) - Spanish supermarket chain Dia (MC:DIDA) said on Monday it has appointed Marcelo Maia as chief executive of its Brazilian subsidiary to lead a restructuring process in Brazil, and as part of a broader global shakeup. Maia will
Sanders, Bloomberg trade insults as Democratic White House race heats up
Today, 00:06
By Tim Reid and John Whitesides RICHMOND, Calif. (Reuters) - Democratic White House contenders Bernie Sanders and Michael Bloomberg stepped up their attacks on each other on Monday, with Sanders accusing the media mogul of trying to buy the election
China's Hubei province reports 93 new coronavirus deaths on Feb. 17
Today, 00:03
BEIJING (Reuters) - The number of deaths in China's central Hubei province from a coronavirus outbreak rose by 93 to 1,789 as of Monday, the province's health commission said on its website on Tuesday. There had been a further 1,807 cases



Latest News
Metro Bank likely to pick interim boss as next CEO: Sky News
18.02.2020 00:15
(Reuters) - Britain's Metro Bank (L:MTRO) is likely to pick acting boss Daniel Frumkin as its next chief executive, Sky News reported https://news.sky.com/story/metro-bank-faces-pressure-to-hand-interim-chief-top-job-11936657 on Monday, citing an unidentified insider. Formal confirmation of an appointment could take place on Tuesday or
Read more
Gazprom deputy CEO Sereda moved to new role at export unit
18.02.2020 00:12
MOSCOW (Reuters) - Gazprom (MCX:GAZP) deputy chief executive officer Mikhail Sereda is to take up a new role at the Russian gas giant's exporting arm, the company said on Monday. Sereda, 49, who is close to Gazprom chief executive Alexei Miller, has been named first deputy of Gazprom Export. He also become general director of Gazprom Trading,
Read more
Spanish supermarket chain Dia appoints new Brazil CEO to lead restructuring
18.02.2020 00:09
SAO PAULO (Reuters) - Spanish supermarket chain Dia (MC:DIDA) said on Monday it has appointed Marcelo Maia as chief executive of its Brazilian subsidiary to lead a restructuring process in Brazil, and as part of a broader global shakeup. Maia will replace Marin Dokozic, who occupied the CEO position for about a year. It was not immediately clear
Read more
Sanders, Bloomberg trade insults as Democratic White House race heats up
18.02.2020 00:06
By Tim Reid and John Whitesides RICHMOND, Calif. (Reuters) - Democratic White House contenders Bernie Sanders and Michael Bloomberg stepped up their attacks on each other on Monday, with Sanders accusing the media mogul of trying to buy the election and Bloomberg saying the senator and his fervent supporters were hurting the party. Sanders
Read more
China's Hubei province reports 93 new coronavirus deaths on Feb. 17
18.02.2020 00:03
BEIJING (Reuters) - The number of deaths in China's central Hubei province from a coronavirus outbreak rose by 93 to 1,789 as of Monday, the province's health commission said on its website on Tuesday. There had been a further 1,807 cases detected in Hubei, the epicenter of the outbreak, taking the total in the province to 59,989.
Read more